Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation.
Palmiro PoltronieriPublished in: Exploration of targeted anti-tumor therapy (2024)
Recently, new data have been added to the interaction between non-coding RNAs (ncRNAs) and epigenetic machinery. Epigenetics includes enzymes involved in DNA methylation, histone modifications, and RNA modifications, and mechanisms underlying chromatin structure, repressive states, and active states operating in transcription. The main focus is on long ncRNAs (lncRNAs) acting as scaffolds to assemble protein complexes. This review does not cover RNA's role in sponging microRNAs, or decoy functions. Several lncRNAs were shown to regulate chromatin activation and repression by interacting with Polycomb repressive complexes and mixed-lineage leukemia (MLL) activating complexes. Various groups reported on enhancer of zeste homolog 2 (EZH2) interactions with regulatory RNAs. Knowledge of the function of these complexes opens the perspective to develop new therapeutics for cancer treatment. Lastly, the interplay between lncRNAs and epitranscriptomic modifications in cancers paves the way for new targets in cancer therapy. The approach to inhibit lncRNAs interaction with protein complexes and perspective to regulate epitrascriptomics-regulated RNAs may bring new compounds as therapeuticals in various types of cancer.
Keyphrases
- dna methylation
- transcription factor
- gene expression
- genome wide
- cancer therapy
- protein protein
- acute myeloid leukemia
- genome wide identification
- binding protein
- dna damage
- healthcare
- small molecule
- network analysis
- signaling pathway
- oxidative stress
- drug delivery
- electronic health record
- squamous cell carcinoma
- single cell
- papillary thyroid
- long non coding rna
- lymph node metastasis
- young adults
- nucleic acid
- protein kinase
- long noncoding rna
- copy number
- squamous cell
- childhood cancer